DK0887344T3 - Quinoliner og quinazoliner, som er nyttige ved terapi - Google Patents
Quinoliner og quinazoliner, som er nyttige ved terapiInfo
- Publication number
- DK0887344T3 DK0887344T3 DK98303897T DK98303897T DK0887344T3 DK 0887344 T3 DK0887344 T3 DK 0887344T3 DK 98303897 T DK98303897 T DK 98303897T DK 98303897 T DK98303897 T DK 98303897T DK 0887344 T3 DK0887344 T3 DK 0887344T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapy
- chem
- formula
- optionally substituted
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Mushroom Cultivation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9711650.3A GB9711650D0 (en) | 1997-06-05 | 1997-06-05 | Compounds useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0887344T3 true DK0887344T3 (da) | 2004-03-08 |
Family
ID=10813629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98303897T DK0887344T3 (da) | 1997-06-05 | 1998-05-18 | Quinoliner og quinazoliner, som er nyttige ved terapi |
Country Status (11)
Country | Link |
---|---|
US (2) | US6048864A (fr) |
EP (1) | EP0887344B1 (fr) |
JP (1) | JP3163281B2 (fr) |
AT (1) | ATE255563T1 (fr) |
BR (1) | BR9801778A (fr) |
CA (1) | CA2239603C (fr) |
DE (1) | DE69820159T2 (fr) |
DK (1) | DK0887344T3 (fr) |
ES (1) | ES2210673T3 (fr) |
GB (1) | GB9711650D0 (fr) |
PT (1) | PT887344E (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9700504D0 (en) | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
GB9708917D0 (en) * | 1997-05-01 | 1997-06-25 | Pfizer Ltd | Compounds useful in therapy |
GB9711650D0 (en) * | 1997-06-05 | 1997-07-30 | Pfizer Ltd | Compounds useful in therapy |
US6191300B1 (en) | 1999-04-16 | 2001-02-20 | Eastman Chemical Company | Process for the preparation of cyclopropylacetonitrile |
KR100420663B1 (ko) * | 2001-01-09 | 2004-03-02 | 주식회사 켐온 | 퀴놀린 유도체, 그의 제조방법 및 그를 포함하는 약학적조성물 |
IL164302A0 (en) * | 2002-03-29 | 2005-12-18 | Chiron Corp | Substituted benzazoles and use thereof as raf kinase inhibitors |
US8299108B2 (en) * | 2002-03-29 | 2012-10-30 | Novartis Ag | Substituted benzazoles and methods of their use as inhibitors of raf kinase |
EP2258365B1 (fr) * | 2003-03-28 | 2013-05-29 | Novartis Vaccines and Diagnostics, Inc. | Utilisation de composés organiques pour potentialiser l'immunité |
KR20060118472A (ko) * | 2003-10-16 | 2006-11-23 | 카이론 코포레이션 | 치환 벤자졸 및 raf 키나아제의 저해제로서 그것의 사용 |
US7928111B2 (en) * | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
US20110160232A1 (en) | 2007-10-04 | 2011-06-30 | Pingda Ren | Certain chemical entities and therapeutic uses thereof |
US8637542B2 (en) | 2008-03-14 | 2014-01-28 | Intellikine, Inc. | Kinase inhibitors and methods of use |
WO2009114874A2 (fr) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Inhibiteurs de kinases (benzothiazole) et procédés d’utilisation associés |
CN102124009B (zh) | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
US8586733B2 (en) | 2008-07-31 | 2013-11-19 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
PL2334639T3 (pl) * | 2008-09-10 | 2013-08-30 | Celgene Corp | Sposoby wytwarzania związków aminosulfonowych |
US8476431B2 (en) * | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
US9458131B2 (en) * | 2011-11-08 | 2016-10-04 | Emory University | Compounds and compositions used to epigenetically transform cells and methods related thereto |
KR20150041040A (ko) | 2012-08-06 | 2015-04-15 | 세노믹스, 인코포레이티드 | 단맛 향미 개질제 |
JO3155B1 (ar) | 2013-02-19 | 2017-09-20 | Senomyx Inc | معدِّل نكهة حلوة |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
ES2974991T3 (es) | 2016-09-19 | 2024-07-02 | Novartis Ag | Combinaciones terapéuticas que comprenden un inhibidor de RAF y un inhibidor de ERK |
US11945813B2 (en) | 2018-08-07 | 2024-04-02 | Firmenich Incorporated | 5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3956495A (en) * | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
US4656174A (en) * | 1982-07-24 | 1987-04-07 | Pfizer Inc. | Quinoline therapeutic agents |
GB8506174D0 (en) * | 1985-03-09 | 1985-04-11 | Pfizer Ltd | 4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives |
GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
US6015819A (en) * | 1992-11-13 | 2000-01-18 | Synaptic Pharmaceutical Corporation | Use of alpha-1C specific compounds to treat benign prostatic hyperplasia |
IT1270993B (it) * | 1994-03-18 | 1997-05-26 | Recordati Chem Pharm | Derivati chinzolilamminici attivi come alfa-antagonisti |
GB9526546D0 (en) * | 1995-12-23 | 1996-02-28 | Pfizer Ltd | Compounds useful in therapy |
IL120302A0 (en) * | 1996-03-27 | 1997-06-10 | Pfizer | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
GB9711650D0 (en) * | 1997-06-05 | 1997-07-30 | Pfizer Ltd | Compounds useful in therapy |
-
1997
- 1997-06-05 GB GBGB9711650.3A patent/GB9711650D0/en active Pending
-
1998
- 1998-04-28 US US09/067,588 patent/US6048864A/en not_active Expired - Fee Related
- 1998-05-18 AT AT98303897T patent/ATE255563T1/de not_active IP Right Cessation
- 1998-05-18 ES ES98303897T patent/ES2210673T3/es not_active Expired - Lifetime
- 1998-05-18 DK DK98303897T patent/DK0887344T3/da active
- 1998-05-18 DE DE69820159T patent/DE69820159T2/de not_active Expired - Fee Related
- 1998-05-18 EP EP98303897A patent/EP0887344B1/fr not_active Expired - Lifetime
- 1998-05-18 PT PT98303897T patent/PT887344E/pt unknown
- 1998-06-03 CA CA002239603A patent/CA2239603C/fr not_active Expired - Fee Related
- 1998-06-04 BR BR9801778A patent/BR9801778A/pt not_active Application Discontinuation
- 1998-06-04 JP JP15610798A patent/JP3163281B2/ja not_active Expired - Fee Related
-
2000
- 2000-02-07 US US09/499,623 patent/US6417194B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB9711650D0 (en) | 1997-07-30 |
JP3163281B2 (ja) | 2001-05-08 |
PT887344E (pt) | 2004-02-27 |
ES2210673T3 (es) | 2004-07-01 |
JPH1112274A (ja) | 1999-01-19 |
US6048864A (en) | 2000-04-11 |
DE69820159T2 (de) | 2004-05-27 |
CA2239603C (fr) | 2003-07-22 |
US6417194B1 (en) | 2002-07-09 |
EP0887344A1 (fr) | 1998-12-30 |
BR9801778A (fr) | 2000-03-21 |
EP0887344B1 (fr) | 2003-12-03 |
CA2239603A1 (fr) | 1998-12-05 |
DE69820159D1 (de) | 2004-01-15 |
ATE255563T1 (de) | 2003-12-15 |
MX9804482A (es) | 1998-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0887344T3 (da) | Quinoliner og quinazoliner, som er nyttige ved terapi | |
YU31699A (sh) | Hinolin i hinazolin jedinjenja korisna u terapiji,naročito u tretmanu benigne hiperplazije prostate | |
CA2236814A1 (fr) | Composes quinoleine et quinazoline utiles en therapie | |
FI904327A0 (fi) | N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
DK0842661T3 (da) | Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning | |
FI943142A (fi) | Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt | |
DK0875506T3 (da) | Quinolin- og quinazolin-forbindelser, som er anvendelige til behandling | |
DE69522703D1 (de) | Aminotetrazol-derivate verwendbar als stickstoff-oxid-synthase inhibitoren | |
NO305973B1 (no) | Anvendelse av quinolin og quinazolinderivater, forbindelsene som sådanne samt antiinflammatoriske midler inneholdende forbindelsene | |
FI914007A0 (fi) | 4-substituerade dihydropyrido (4,3-d) pyrimidiner som smaertslindrande och lokala inflammationshaemmande medel vid vaord av hudsjukdomar. | |
ATE140229T1 (de) | Benzoxazepinon-verfahren | |
FI914219A0 (fi) | 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel. | |
DK369289A (da) | Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler | |
FI912499A0 (fi) | Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. |